Page last updated: 2024-08-21

quinazolines and zm 252868

quinazolines has been researched along with zm 252868 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's5 (50.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrow, D; Dutkowski, CM; Harper, ME; Jones, HE; Nicholson, RI; Wakeling, AE1
Arteaga, CL; Guyer, CA; Ramsey, TT; Shawver, LK1
Bartlett, JM; Gordge, P; Langdon, SP; Leake, RE; Macleod, KG; Miller, EP; Miller, WR; Rabiasz, G; Rae, AL; Simpson, BJ; Smyth, J1
Ben-Bassat, H; Chaouat, M; Chen, H; Gazit, A; Harzstark, Z; Klein, BY; Levitzki, A; Levitzki, R; McCollough, J; McMahon, J; Narog, B; Powell, TJ; Shawver, L; Shenoy, N; Tang, C1
Arteaga, CL; Busse, D; Doughty, RS; Flanagan, WM; Price, JO; Ramsey, TT; Russell, WE; Shawver, LK1
Barrow, D; Dutkowski, CM; Goddard, L; Harper, ME; Jones, HE; Nicholson, RI; Smith, C1
Assender, J; Barrow, D; Dewhurst, OL; Dutkowski, CM; Glynne-Jones, E; Goddard, L; Harper, ME; Nicholson, RI; Wakeling, AE1
Grunt, TW1
Banasik, M; Dytnerska, K; Lewkowicz, N; Lewkowicz, P; Tchórzewski, H1
Almenara, JA; Campbell, DJ; Dewitt, JL; Oyesanya, RA; Sirica, AE; Zhang, Z1

Other Studies

10 other study(ies) available for quinazolines and zm 252868

ArticleYear
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.
    International journal of cancer, 1997, Jun-11, Volume: 71, Issue:6

    Topics: Cell Division; Enzyme Inhibitors; ErbB Receptors; Humans; Immunohistochemistry; Male; Phosphorylation; Prostatic Neoplasms; Quinazolines; Signal Transduction; Tumor Cells, Cultured

1997
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
    The Journal of biological chemistry, 1997, Sep-12, Volume: 272, Issue:37

    Topics: Adenosine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Binding Sites; Carrier Proteins; Dimerization; Enzyme Inhibitors; ErbB Receptors; Glycoproteins; Humans; Ligands; Neuregulin-1; Nitriles; Phosphorylation; Protein Binding; Protein Conformation; Quinazolines; Receptor, ErbB-2; Signal Transduction; Tumor Cells, Cultured; Tyrphostins

1997
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
    British journal of cancer, 1999, Volume: 79, Issue:7-8

    Topics: Cell Division; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Ovarian Neoplasms; Phosphorylation; Proto-Oncogene Proteins; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Transforming Growth Factor alpha; Tumor Cells, Cultured

1999
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors.
    The British journal of dermatology, 1999, Volume: 141, Issue:5

    Topics: Animals; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermis; ErbB Receptors; Humans; Keratinocytes; Mice; Psoriasis; Quinazolines; Skin Absorption; Tumor Cells, Cultured; Tyrphostins

1999
Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity.
    The Journal of biological chemistry, 2000, Mar-10, Volume: 275, Issue:10

    Topics: Animals; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; ErbB Receptors; Female; G1 Phase; Humans; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinazolines; Retinoblastoma Protein; Tumor Suppressor Proteins; Tyrphostins; Up-Regulation

2000
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.
    The Prostate, 2001, Sep-15, Volume: 49, Issue:1

    Topics: Androgen Antagonists; Anilides; Blotting, Western; Cell Division; Drug Interactions; Enzyme Inhibitors; ErbB Receptors; Humans; Immunohistochemistry; Male; Nitriles; Prostatic Neoplasms; Quinazolines; Signal Transduction; Tosyl Compounds; Tumor Cells, Cultured

2001
Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
    The Prostate, 2002, Jun-01, Volume: 52, Issue:1

    Topics: Adenocarcinoma; Apoptosis; Blotting, Northern; Blotting, Western; Cell Count; Cell Cycle; Cell Division; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Quinazolines; RNA, Messenger; Signal Transduction; Transforming Growth Factor alpha; Tumor Cells, Cultured

2002
Tyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells.
    Cancer letters, 2003, Jan-28, Volume: 189, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Benzothiazoles; Cell Division; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Quinazolines; Receptor, ErbB-2; Tretinoin; Tumor Cells, Cultured; Tyrphostins

2003
Epidermal growth factor enhances TNF-alpha-induced priming of human neutrophils.
    Immunology letters, 2005, Jan-31, Volume: 96, Issue:2

    Topics: CD11b Antigen; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Humans; Inflammation; Interleukin-8; Neutrophils; Phagocytosis; Protein Kinase Inhibitors; Quinazolines; Reactive Oxygen Species; Respiratory Burst; Tumor Necrosis Factor-alpha; Tyrphostins

2005
Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; ErbB Receptors; Humans; Lapatinib; Protein Kinase Inhibitors; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction; Tyrphostins

2010